Colm McDonald
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Colm McDonald has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Dara M. Cannon
University of Galway
21 shared publications - Brian Hallahan
University of Galway
19 shared publications - Derek W. Morris
University of Galway
11 shared publications Gloria Roberts
10 shared publicationsBrian Hallahan
School of Medicine, University of Galway
9 shared publications- Eduard Vieta
University of Barcelona: Universitat de Barcelona
9 shared publications
Latest Publications
- Open Access
- 4 November 2026
- Published by Springer Nature in Research Square
Individualized Structural Brain Deviations in Bipolar I Disorder: a Normative Modeling Study of 4 660 ENIGMA Participants
Bipolar disorder (BD) is a prevalent psychiatric condition characterized by marked clinical and neuroanatomical heterogeneity. Prior neuroimaging studies have used case-control comparisons yielding small to moderate effect sizes for group differences. Large and diverse samples are needed to map heterogeneity within BD. Here, we used individualized brain morphometry deviations derived from normative modeling for three MRI-based measures (regional cortical thickness, regional surface area, and subcortical volumes). We applied this approach to a large international sample of 4 660 individuals (1 145 with bipolar I disorder and 3 515 healthy controls) from the ENIGMA Bipolar Disorder Working Group consortium (age range = 8–80, female = 53.15%) and examined the distribution of deviations within the bipolar disorder group, differences between healthy controls and individuals with bipolar disorder, and associations between neuroanatomical deviations and clinical variables. We found that individuals with bipolar disorder showed a higher proportion of localized extreme deviations, notably negative cortical thickness deviations in regions consistently reported as thinner in prior studies (the left superior frontal gyrus, bilateral inferior frontal gyrus (pars opercularis), left precuneus) and subcortical volume negative deviations in the left hippocampus. In addition, ROI-level deviations in the left middle temporal gyrus and the left inferior temporal gyrus were associated with longer illness duration. This is the largest study to date exploring individualized deviations as neuroanatomical features associated with bipolar disorder. Our findings suggest that neuroanatomical heterogeneity is a core feature of bipolar disorder, with preferential left-lateralized cortical-hippocampal involvement pointing to spatially structured heterogeneity.
- 4 November 2026
- Published by Springer Nature in Research Square
Open AccessIndividualized Structural Brain Deviations in Bipolar I Disorder: a Normative Modeling Study of 4 660 ENIGMA Participants
Bipolar disorder (BD) is a prevalent psychiatric condition characterized by marked clinical and neuroanatomical heterogeneity. Prior neuroimaging studies have used case-control comparisons yielding small to moderate effect sizes for group differences. Large and diverse samples are needed to map heterogeneity within BD. Here, we used individualized brain morphometry deviations derived from normative modeling for three MRI-based measures (regional cortical thickness, regional surface area, and subcortical volumes). We applied this approach to a large international sample of 4 660 individuals (1 145 with bipolar I disorder and 3 515 healthy controls) from the ENIGMA Bipolar Disorder Working Group consortium (age range = 8–80, female = 53.15%) and examined the distribution of deviations within the bipolar disorder group, differences between healthy controls and individuals with bipolar disorder, and associations between neuroanatomical deviations and clinical variables. We found that individuals with bipolar disorder showed a higher proportion of localized extreme deviations, notably negative cortical thickness deviations in regions consistently reported as thinner in prior studies (the left superior frontal gyrus, bilateral inferior frontal gyrus (pars opercularis), left precuneus) and subcortical volume negative deviations in the left hippocampus. In addition, ROI-level deviations in the left middle temporal gyrus and the left inferior temporal gyrus were associated with longer illness duration. This is the largest study to date exploring individualized deviations as neuroanatomical features associated with bipolar disorder. Our findings suggest that neuroanatomical heterogeneity is a core feature of bipolar disorder, with preferential left-lateralized cortical-hippocampal involvement pointing to spatially structured heterogeneity.
- Open Access
- 23 October 2026
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 56, e342
Distinct profiles of white matter diffusivity in obesity and bipolar disorders: An ENIGMA bipolar disorders study in 2166 individuals
Background: Bipolar disorders (BD) are associated with a wide range of brain white matter abnormalities, but results vary across studies. This heterogeneity likely relates to effects of additional clinical/diagnostic variables, including medications and obesity, on white matter in BD. In this mega-analysis, we studied the links between relevant clinical variables and four diffusivity measures. Methods: We obtained diffusion tensor imaging-derived fractional anisotropy (FA), mean, axial, and radial diffusivity (MD, AD, RD) values from 910 individuals with BD and 1256 healthy controls across 16 research sites in the ENIGMA-BD Working Group. We used principal component analysis to detect patterns of covariance across white matter tracts and studied associations between multivariate patterns of white matter alterations and demographic and clinical variables, including body mass index (BMI), medications, and diagnostic information, using mixed regression models. Results: Higher BMI was associated with lower PC1 FA and higher PC1 RD; BD was associated with higher PC1 MD, while treatment with antiepileptic medications was associated with lower PC1 FA, higher PC1 MD, and PC1 RD. Conclusions: We found FA and MD are weakly associated, providing complementary information, and there are unique associations between specific diffusivity measures and clinical predictors. Treatment with antiepileptics may inflate the statistical effects of BD on white matter. By using all diffusivity measures and accounting for additional clinical factors, we can gain new insights into brain correlates of severe mental illness.
- 23 October 2026
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 56, e342
Open AccessDistinct profiles of white matter diffusivity in obesity and bipolar disorders: An ENIGMA bipolar disorders study in 2166 individuals
Background: Bipolar disorders (BD) are associated with a wide range of brain white matter abnormalities, but results vary across studies. This heterogeneity likely relates to effects of additional clinical/diagnostic variables, including medications and obesity, on white matter in BD. In this mega-analysis, we studied the links between relevant clinical variables and four diffusivity measures. Methods: We obtained diffusion tensor imaging-derived fractional anisotropy (FA), mean, axial, and radial diffusivity (MD, AD, RD) values from 910 individuals with BD and 1256 healthy controls across 16 research sites in the ENIGMA-BD Working Group. We used principal component analysis to detect patterns of covariance across white matter tracts and studied associations between multivariate patterns of white matter alterations and demographic and clinical variables, including body mass index (BMI), medications, and diagnostic information, using mixed regression models. Results: Higher BMI was associated with lower PC1 FA and higher PC1 RD; BD was associated with higher PC1 MD, while treatment with antiepileptic medications was associated with lower PC1 FA, higher PC1 MD, and PC1 RD. Conclusions: We found FA and MD are weakly associated, providing complementary information, and there are unique associations between specific diffusivity measures and clinical predictors. Treatment with antiepileptics may inflate the statistical effects of BD on white matter. By using all diffusivity measures and accounting for additional clinical factors, we can gain new insights into brain correlates of severe mental illness.
- Open Access
- 13 September 2026
- Published by Wiley in European Journal of Neuroscience
- Vol. 64 (5) , e70675
Childhood Trauma and Frontoparietal Network Connectivity During Working Memory Task Performance in Individuals With Schizophrenia and Healthy Participants
Schizophrenia is associated with altered frontoparietal connectivity, which supports higher‐order cognition, including working memory. Childhood trauma has been linked to altered functional connectivity and reduced cognitive performance in individuals with schizophrenia and controls. Prior evidence suggests that trauma‐related default mode dysconnectivity mediates the association between trauma and cognition. We hypothesised that childhood trauma would be associated with altered frontoparietal connectivity during a working memory task and that such connectivity changes would mediate the relationship between trauma and working memory. Childhood trauma, working memory and fMRI data were collected from individuals with schizophrenia or schizoaffective disorder ( n = 38) and controls ( n = 128). fMRI data were preprocessed in CONN, and seed‐based connectivity analyses were performed for four frontoparietal seeds (bilateral dorsolateral prefrontal and posterior parietal cortices). Connectivity was contrasted across (a) diagnosis and (b) trauma severity. Moderated mediation analyses tested the associations between trauma, connectivity and working memory, with diagnosis as a moderator. Across all participants, higher physical neglect severity predicted poorer working memory performance. Stronger inverse connectivity between left dorsolateral prefrontal and frontal medial cortices predicted better working memory performance. As expected, patients showed widespread frontoparietal dysconnectivity relative to controls, but no differences in frontoparietal connectivity were observed across trauma severity groups. Frontoparietal connectivity did not mediate the association between trauma and working memory, although diagnosis moderated both the trauma‐connectivity and connectivity‐cognition associations. We conclude that, unlike previous evidence suggesting a mediating role for the default mode network, frontoparietal connectivity did not mediate the trauma‐cognition association, possibly suggesting the unique significance of default mode network dysconnectivity in linking trauma to cognition in psychosis.
- 13 September 2026
- Published by Wiley in European Journal of Neuroscience
- Vol. 64 (5) , e70675
Open AccessChildhood Trauma and Frontoparietal Network Connectivity During Working Memory Task Performance in Individuals With Schizophrenia and Healthy Participants
Schizophrenia is associated with altered frontoparietal connectivity, which supports higher‐order cognition, including working memory. Childhood trauma has been linked to altered functional connectivity and reduced cognitive performance in individuals with schizophrenia and controls. Prior evidence suggests that trauma‐related default mode dysconnectivity mediates the association between trauma and cognition. We hypothesised that childhood trauma would be associated with altered frontoparietal connectivity during a working memory task and that such connectivity changes would mediate the relationship between trauma and working memory. Childhood trauma, working memory and fMRI data were collected from individuals with schizophrenia or schizoaffective disorder ( n = 38) and controls ( n = 128). fMRI data were preprocessed in CONN, and seed‐based connectivity analyses were performed for four frontoparietal seeds (bilateral dorsolateral prefrontal and posterior parietal cortices). Connectivity was contrasted across (a) diagnosis and (b) trauma severity. Moderated mediation analyses tested the associations between trauma, connectivity and working memory, with diagnosis as a moderator. Across all participants, higher physical neglect severity predicted poorer working memory performance. Stronger inverse connectivity between left dorsolateral prefrontal and frontal medial cortices predicted better working memory performance. As expected, patients showed widespread frontoparietal dysconnectivity relative to controls, but no differences in frontoparietal connectivity were observed across trauma severity groups. Frontoparietal connectivity did not mediate the association between trauma and working memory, although diagnosis moderated both the trauma‐connectivity and connectivity‐cognition associations. We conclude that, unlike previous evidence suggesting a mediating role for the default mode network, frontoparietal connectivity did not mediate the trauma‐cognition association, possibly suggesting the unique significance of default mode network dysconnectivity in linking trauma to cognition in psychosis.
- Open Access
- 21 May 2026
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (9) , 5423-5430
White matter microstructure in relatives of people with schizophrenia or bipolar disorder: an ENIGMA meta-analysis
Bipolar and psychotic disorders are highly heritable and associated with widespread white matter microstructure abnormalities. In this project, we compare white matter microstructure of unaffected first-degree relatives of individuals with bipolar disorder (FDR-BD) or psychotic disorder (FDR-SZ) to that of control participants. As secondary, exploratory aims, we examined the associations of childhood traumatic experiences and working memory with white matter microstructure across relatives and controls. Finally, we compared participants with BD or SZ to controls. We combined 11 samples from 9 institutions with 408 FDR-BD, 542 FDR-SZ, 841 controls, 255 BD and 464 SZ. Analysis of the diffusion-weighted imaging data followed the ENIGMA pipeline protocols, resulting in mean fractional anisotropy (FA). Sample-level analyses were linear mixed-effects models with group as the main predictor, adjusting for age and sex and correcting for dependence between family members. Samples were combined using random-effects meta-analysis. FDR-BD showed higher FA in the posterior limb of the internal capsule (PLIC) than controls. FDR-SZ did not demonstrate any FA differences from controls. Participants with BD or SZ diagnoses from the same samples did show the expected lower FA than controls in several tracts. Working memory scores were more positively related to FA in the PLIC in FDR-SZ than in controls. The level of childhood traumatic experiences was not related to FA. White matter deficits observed in people with SZ and BD were not detected in FDR-BD and FDR-SZ, suggesting that these findings in patients are not due to familial risk but may pertain to illness itself.
- 21 May 2026
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (9) , 5423-5430
Open AccessWhite matter microstructure in relatives of people with schizophrenia or bipolar disorder: an ENIGMA meta-analysis
Bipolar and psychotic disorders are highly heritable and associated with widespread white matter microstructure abnormalities. In this project, we compare white matter microstructure of unaffected first-degree relatives of individuals with bipolar disorder (FDR-BD) or psychotic disorder (FDR-SZ) to that of control participants. As secondary, exploratory aims, we examined the associations of childhood traumatic experiences and working memory with white matter microstructure across relatives and controls. Finally, we compared participants with BD or SZ to controls. We combined 11 samples from 9 institutions with 408 FDR-BD, 542 FDR-SZ, 841 controls, 255 BD and 464 SZ. Analysis of the diffusion-weighted imaging data followed the ENIGMA pipeline protocols, resulting in mean fractional anisotropy (FA). Sample-level analyses were linear mixed-effects models with group as the main predictor, adjusting for age and sex and correcting for dependence between family members. Samples were combined using random-effects meta-analysis. FDR-BD showed higher FA in the posterior limb of the internal capsule (PLIC) than controls. FDR-SZ did not demonstrate any FA differences from controls. Participants with BD or SZ diagnoses from the same samples did show the expected lower FA than controls in several tracts. Working memory scores were more positively related to FA in the PLIC in FDR-SZ than in controls. The level of childhood traumatic experiences was not related to FA. White matter deficits observed in people with SZ and BD were not detected in FDR-BD and FDR-SZ, suggesting that these findings in patients are not due to familial risk but may pertain to illness itself.
- 27 March 2026
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (8) , 4418-4432
Cortical morphometry might predict currently prescribed vs. discontinued medications in bipolar disorder, even after controlling for the cumulative dose effects: An ENIGMA mega-analysis
Recent research suggests that brain anatomy may help identify the most effective pharmacological treatment for each individual with bipolar disorder and reduce trial-and-error prescribing. We aimed to investigate whether brain anatomy predicts whether a medication is currently prescribed or has been discontinued, as a proxy for treatment effectiveness. The rationale is that medications that provide clinical benefit without unacceptable side effects are likely to be continued, whereas those with limited benefit or poor tolerability are typically discontinued. We used T1-weighted MRI from twelve ENIGMA-BD cohorts (n = 2462; 473 individuals with BD [61% female, age 18-73] and 1989 controls) to derive regional cortical thickness and surface area and subcortical volumes. Site differences were harmonized using ComBat models fitted on controls' data. Within cross-validation, models were trained to first adjust for cumulative dose and other covariates and then predict medication status. On test sets, current prescription (vs. discontinuation) of lithium was predicted by greater cortical thickness and reduced surface area, whereas current prescription (vs. discontinuation) of antidepressants and atypical antipsychotics was predicted by greater cortical thickness. Predictive regions for atypical antipsychotics were generally consistent across subgroups of age, gender, illness duration, and history of psychosis, and in the largest site, and differed from those associated with cumulative effects of medication on the cortex. Predictions were poor for subcortical volumes and for antiepileptic mood stabilizers and typical antipsychotics. These findings provide preliminary support that cortical anatomy may help inform future development of biomarkers for treatment selection, pending validation in longitudinal studies.
- 27 March 2026
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (8) , 4418-4432
Cortical morphometry might predict currently prescribed vs. discontinued medications in bipolar disorder, even after controlling for the cumulative dose effects: An ENIGMA mega-analysis
Recent research suggests that brain anatomy may help identify the most effective pharmacological treatment for each individual with bipolar disorder and reduce trial-and-error prescribing. We aimed to investigate whether brain anatomy predicts whether a medication is currently prescribed or has been discontinued, as a proxy for treatment effectiveness. The rationale is that medications that provide clinical benefit without unacceptable side effects are likely to be continued, whereas those with limited benefit or poor tolerability are typically discontinued. We used T1-weighted MRI from twelve ENIGMA-BD cohorts (n = 2462; 473 individuals with BD [61% female, age 18-73] and 1989 controls) to derive regional cortical thickness and surface area and subcortical volumes. Site differences were harmonized using ComBat models fitted on controls' data. Within cross-validation, models were trained to first adjust for cumulative dose and other covariates and then predict medication status. On test sets, current prescription (vs. discontinuation) of lithium was predicted by greater cortical thickness and reduced surface area, whereas current prescription (vs. discontinuation) of antidepressants and atypical antipsychotics was predicted by greater cortical thickness. Predictive regions for atypical antipsychotics were generally consistent across subgroups of age, gender, illness duration, and history of psychosis, and in the largest site, and differed from those associated with cumulative effects of medication on the cortex. Predictions were poor for subcortical volumes and for antiepileptic mood stabilizers and typical antipsychotics. These findings provide preliminary support that cortical anatomy may help inform future development of biomarkers for treatment selection, pending validation in longitudinal studies.
- Open Access
- 6 March 2026
- Published by Springer Nature in Schizophrenia
- Vol. 12 (1)
An ENIGMA Consortium study of the relationship between white matter microstructure and positive and negative symptom severity in patients with schizophrenia
Symptom severity in schizophrenia has been repeatedly associated with thinner cortical gray matter. While global and regional white matter microstructure alterations in schizophrenia are well-documented, their association with clinical symptom severity remains unclear. As this is likely due to methodological heterogeneity across studies, we tested whether symptom severity in schizophrenia was associated with regional and global white matter alterations using standardized methods. We hypothesized that positive symptom severity would be associated with temporal white matter changes and that negative symptom severity would be associated with alterations in frontal white matter. Using a standardized fractional anisotropy (FA) analysis pipeline developed by the ENIGMA consortium, we conducted a meta-analysis of the association between white matter microstructure and symptom severity in n = 1025 (ages 16–68 years; 369 women/656 men) across 19 ENIGMA sites. Where significant heterogeneity was detected across sites, we examined whether variation in association strength between white matter microstructure and symptom severity was explained by duration of illness and/or current antipsychotic use. Positive symptom severity was significantly associated with white matter microstructure as measured using temporal lobe FA and global FA. Negative symptom severity showed no significant association with white matter microstructure as measured using frontal lobe FA or global FA. Significant heterogeneity across sites was observed for the negative symptom analysis, explained partly by duration of illness. Post-hoc exploratory analyses identified one site as disproportionately contributing to this heterogeneity, and when removed, negative symptom severity was significantly associated with both global and frontal FA. These findings support the view of schizophrenia as a disorder of brain connectivity, in a manner relevant to understanding variation in clinical symptom severity.
- 6 March 2026
- Published by Springer Nature in Schizophrenia
- Vol. 12 (1)
Open AccessAn ENIGMA Consortium study of the relationship between white matter microstructure and positive and negative symptom severity in patients with schizophrenia
Symptom severity in schizophrenia has been repeatedly associated with thinner cortical gray matter. While global and regional white matter microstructure alterations in schizophrenia are well-documented, their association with clinical symptom severity remains unclear. As this is likely due to methodological heterogeneity across studies, we tested whether symptom severity in schizophrenia was associated with regional and global white matter alterations using standardized methods. We hypothesized that positive symptom severity would be associated with temporal white matter changes and that negative symptom severity would be associated with alterations in frontal white matter. Using a standardized fractional anisotropy (FA) analysis pipeline developed by the ENIGMA consortium, we conducted a meta-analysis of the association between white matter microstructure and symptom severity in n = 1025 (ages 16–68 years; 369 women/656 men) across 19 ENIGMA sites. Where significant heterogeneity was detected across sites, we examined whether variation in association strength between white matter microstructure and symptom severity was explained by duration of illness and/or current antipsychotic use. Positive symptom severity was significantly associated with white matter microstructure as measured using temporal lobe FA and global FA. Negative symptom severity showed no significant association with white matter microstructure as measured using frontal lobe FA or global FA. Significant heterogeneity across sites was observed for the negative symptom analysis, explained partly by duration of illness. Post-hoc exploratory analyses identified one site as disproportionately contributing to this heterogeneity, and when removed, negative symptom severity was significantly associated with both global and frontal FA. These findings support the view of schizophrenia as a disorder of brain connectivity, in a manner relevant to understanding variation in clinical symptom severity.
- Open Access
- 3 March 2026
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 56, e63
Investigating the relationship between Toll-like receptor activity, low-grade inflammation, cognitive deficits, and antipsychotic drug dose in schizophrenia patients: a moderation analysis
Background: Schizophrenia (SZ) is a debilitating psychiatric disorder where patients experience cognitive decline. Antipsychotic drugs alleviate positive symptoms but do not improve cognitive performance. We previously demonstrated that Toll-like receptors (TLRs), involved in cytokine production, can predict cognitive deficits in SZ patients. In this study, we aim to investigate the potential moderating effects of antipsychotic drugs on the associations between cytokines, TLRs, and cognition. Methods: In total, 280 participants (201 controls and 79 cases of SZ) were recruited in Ireland. Venous blood from the participants was stimulated with TLR ligands. Levels of cytokines were measured from plasma and post-blood stimulation. The participants were administered a battery of cognitive tasks using the Cambridge Neuropsychological Test Automated Battery and Wechsler Adult Intelligence Scale-IIIR. Olanzapine equivalents were calculated using the defined daily dose method. Results: The results indicate that antipsychotic drug dose does not predict TLR activity or cognition, indicating that antipsychotic drug dose does not have a direct effect on cognition or TLR activity. However, the relationship between TLR4 activity and visual learning and memory is moderated by the antipsychotic drug dose ( B = −0.065; p < 0.001), where increasing doses have a decreasing impact on their relationship. Conclusions: Our data indicate that the dose of antipsychotic drugs alone cannot predict changes in cognitive performance and TLR4-activity. It also suggests that antipsychotic drug doses significantly affect TLR activity and its relationship with cognition. These effects are more pronounced on some domains than others. These findings open up new avenues for understanding the complex interplay between antipsychotic drugs, TLRs, and cognitive deficits in SZ.
- 3 March 2026
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 56, e63
Open AccessInvestigating the relationship between Toll-like receptor activity, low-grade inflammation, cognitive deficits, and antipsychotic drug dose in schizophrenia patients: a moderation analysis
Background: Schizophrenia (SZ) is a debilitating psychiatric disorder where patients experience cognitive decline. Antipsychotic drugs alleviate positive symptoms but do not improve cognitive performance. We previously demonstrated that Toll-like receptors (TLRs), involved in cytokine production, can predict cognitive deficits in SZ patients. In this study, we aim to investigate the potential moderating effects of antipsychotic drugs on the associations between cytokines, TLRs, and cognition. Methods: In total, 280 participants (201 controls and 79 cases of SZ) were recruited in Ireland. Venous blood from the participants was stimulated with TLR ligands. Levels of cytokines were measured from plasma and post-blood stimulation. The participants were administered a battery of cognitive tasks using the Cambridge Neuropsychological Test Automated Battery and Wechsler Adult Intelligence Scale-IIIR. Olanzapine equivalents were calculated using the defined daily dose method. Results: The results indicate that antipsychotic drug dose does not predict TLR activity or cognition, indicating that antipsychotic drug dose does not have a direct effect on cognition or TLR activity. However, the relationship between TLR4 activity and visual learning and memory is moderated by the antipsychotic drug dose ( B = −0.065; p < 0.001), where increasing doses have a decreasing impact on their relationship. Conclusions: Our data indicate that the dose of antipsychotic drugs alone cannot predict changes in cognitive performance and TLR4-activity. It also suggests that antipsychotic drug doses significantly affect TLR activity and its relationship with cognition. These effects are more pronounced on some domains than others. These findings open up new avenues for understanding the complex interplay between antipsychotic drugs, TLRs, and cognitive deficits in SZ.
- Open Access
- 15 January 2026
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (5) , 2941-2953
Psychotropic medications and their interactions with subcortical brain volume in bipolar disorder: An ENIGMA mega-analysis
MRI studies in bipolar disorder (BD) have yielded inconsistent findings, partly due to the varied use of psychotropic medications. This study utilised a mega-analysis approach, accounting for concurrent medication status (syndrome-based and Neuroscience-based Nomenclature (NbN) classifications), in order to assess the association of medication status with subcortical brain volumes in BD. Data from 2,664 BD patients and 4,065 controls (CN) were pooled from 34 research groups as part of the ENIGMA Bipolar Disorder Working Group. Standardized ENIGMA protocols were used to measure subcortical brain volumes. Linear-mixed-effects regression evaluated the association between psychotropic medications and subcortical volumes, and moderation analyses explored interactions. Medication-free patients (n = 410) showed mild ventricular enlargement (d = 0.07) and increased putamen volume (d = 0.06) compared to CN. Patients taking psychotropic medications exhibited smaller subcortical volumes (d = -0.06 to -0.11) and larger ventricles (d = 0.11 to 0.19). Use of antiepileptic and antipsychotic medications was associated with smaller hippocampal and thalamic volumes (d = -0.07 to -0.14), while NbN classification indicated that the categories of ‘valproate’ and ‘dopamine and other monoamine receptor antagonists’ are key variables when considering volume differences between BD and CN. Concurrent lithium use weakened the negative association between antiepileptic use and hippocampal volume (β = 0.19, q = 0.038) in patients. Medication status is associated with altered subcortical brain volumes in BD. The NbN classification provides a useful framework for future studies, emphasizing the need for comprehensive longitudinal research to further unravel complex clinical-pharmacological-neurobiological interactions in BD.
- 15 January 2026
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (5) , 2941-2953
Open AccessPsychotropic medications and their interactions with subcortical brain volume in bipolar disorder: An ENIGMA mega-analysis
MRI studies in bipolar disorder (BD) have yielded inconsistent findings, partly due to the varied use of psychotropic medications. This study utilised a mega-analysis approach, accounting for concurrent medication status (syndrome-based and Neuroscience-based Nomenclature (NbN) classifications), in order to assess the association of medication status with subcortical brain volumes in BD. Data from 2,664 BD patients and 4,065 controls (CN) were pooled from 34 research groups as part of the ENIGMA Bipolar Disorder Working Group. Standardized ENIGMA protocols were used to measure subcortical brain volumes. Linear-mixed-effects regression evaluated the association between psychotropic medications and subcortical volumes, and moderation analyses explored interactions. Medication-free patients (n = 410) showed mild ventricular enlargement (d = 0.07) and increased putamen volume (d = 0.06) compared to CN. Patients taking psychotropic medications exhibited smaller subcortical volumes (d = -0.06 to -0.11) and larger ventricles (d = 0.11 to 0.19). Use of antiepileptic and antipsychotic medications was associated with smaller hippocampal and thalamic volumes (d = -0.07 to -0.14), while NbN classification indicated that the categories of ‘valproate’ and ‘dopamine and other monoamine receptor antagonists’ are key variables when considering volume differences between BD and CN. Concurrent lithium use weakened the negative association between antiepileptic use and hippocampal volume (β = 0.19, q = 0.038) in patients. Medication status is associated with altered subcortical brain volumes in BD. The NbN classification provides a useful framework for future studies, emphasizing the need for comprehensive longitudinal research to further unravel complex clinical-pharmacological-neurobiological interactions in BD.
- Open Access
- 21 November 2025
- Published by Springer Nature in Translational Psychiatry
- Vol. 15 (1) , 491
Effect of polygenic scores on the relationship between psychosis and cognition
Cognitive impairment is an important but often under-researched symptom in psychosis. Both psychosis and cognition are highly heritable and there is evidence of a genetic effect on the relationship between them. Using samples of adults ( N = 4 506) and children ( N = 10 981), we investigated the effect of schizophrenia and bipolar disorder polygenic scores on cognitive performance, and intelligence and educational attainment polygenic scores on psychosis presentation. Schizophrenia polygenic score was negatively associated with visuospatial processing in adults (beta: −0.0569; 95% confidence interval [CI]: −0.0926, −0.0212) and working memory (beta: −0.0432; 95% CI: −0.0697, −0.0168), processing speed (beta: −0.0491; 95% CI: −0.0760, −0.0223), episodic memory (betas: −0.0581 to −0.0430; 95% CIs: −0.0847, −0.0162), executive functioning (beta: −0.0423; 95% CI: −0.0692, −0.0155), fluid intelligence (beta: −0.0583; 95% CI: −0.0847, −0.0320), and total intelligence (beta: −0.0458; 95% CI: −0.0709, −0.0206) in children. Bipolar disorder polygenic score was not associated with any cognitive domains studied. Lower polygenic scores for intelligence were associated with greater odds of psychosis in adults (odds ratio [OR]: 0.886; 95% CI: 0.811–0.968). In children, lower polygenic scores for both intelligence (OR: 0.829; 95% CI: 0.777–0.884) and educational attainment (OR: 0.771; 95% CI: 0.724–0.821) were associated with greater odds of psychotic-like experiences. Our findings suggest that polygenic scores for both cognitive phenotypes and psychosis phenotypes are implicated in the relationship between psychosis and cognitive performance. Further research is needed to determine the direction of this effect and the mechanisms by which it occurs.
- 21 November 2025
- Published by Springer Nature in Translational Psychiatry
- Vol. 15 (1) , 491
Open AccessEffect of polygenic scores on the relationship between psychosis and cognition
Cognitive impairment is an important but often under-researched symptom in psychosis. Both psychosis and cognition are highly heritable and there is evidence of a genetic effect on the relationship between them. Using samples of adults ( N = 4 506) and children ( N = 10 981), we investigated the effect of schizophrenia and bipolar disorder polygenic scores on cognitive performance, and intelligence and educational attainment polygenic scores on psychosis presentation. Schizophrenia polygenic score was negatively associated with visuospatial processing in adults (beta: −0.0569; 95% confidence interval [CI]: −0.0926, −0.0212) and working memory (beta: −0.0432; 95% CI: −0.0697, −0.0168), processing speed (beta: −0.0491; 95% CI: −0.0760, −0.0223), episodic memory (betas: −0.0581 to −0.0430; 95% CIs: −0.0847, −0.0162), executive functioning (beta: −0.0423; 95% CI: −0.0692, −0.0155), fluid intelligence (beta: −0.0583; 95% CI: −0.0847, −0.0320), and total intelligence (beta: −0.0458; 95% CI: −0.0709, −0.0206) in children. Bipolar disorder polygenic score was not associated with any cognitive domains studied. Lower polygenic scores for intelligence were associated with greater odds of psychosis in adults (odds ratio [OR]: 0.886; 95% CI: 0.811–0.968). In children, lower polygenic scores for both intelligence (OR: 0.829; 95% CI: 0.777–0.884) and educational attainment (OR: 0.771; 95% CI: 0.724–0.821) were associated with greater odds of psychotic-like experiences. Our findings suggest that polygenic scores for both cognitive phenotypes and psychosis phenotypes are implicated in the relationship between psychosis and cognitive performance. Further research is needed to determine the direction of this effect and the mechanisms by which it occurs.
- Open Access
- 7 November 2024
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 180, 451-461
Structural brain connectivity does not associate with childhood trauma in individuals with schizophrenia
- 7 November 2024
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 180, 451-461
Open AccessStructural brain connectivity does not associate with childhood trauma in individuals with schizophrenia